Investors

Investors

Investors

Featured

Novartis Quarterly Financial Results

Novartis delivered growth on top and bottom line in all divisions in Q3.

Read More

Share Price

SIX
NYSE

CHF as of Oct 24, 11:19 CEST

USD as of Oct 23, 16:02 EDT

View stock performance

Media Release / Oct 24

Novartis delivered growth on top and bottom line in all divisions in Q3

Media Release / Oct 23

Novartis combination adjuvant therapy Tafinlar® + Mekinist® receives FDA Breakthrough Therapy Designation for stage III BRAF V600 mutation-positive melanoma patients

In this section

Event Calendar: View recent presentations and learn more about upcoming events.
Company Overview: Learn about Novartis leaders, corporate governance, our clinical pipeline and more.
Share Data & Analysis: Access information on Novartis share performance and dividend payouts.
Financial Data: Review and download annual and quarterly reports, SEC filings and product sales information.
Shareholder Information: Find information for shareholders and answers to frequently asked questions.
Investor Contact: For questions about Investor Relations or the Share Registry, please contact our team.

Quick Links

News

Novartis Annual Report 2016

Financial Data

Quarterly Financial Results

Company Overview

Novartis Fact Sheet

Shareholder Information

For Japanese Investors

Corporate Responsibility

We apply our expertise in science and innovation to society’s biggest health challenges. Responsibility is a core part of our business strategy.